Edwards Lifesciences Files Proxy Materials
Ticker: EW · Form: DEFA14A · Filed: Apr 14, 2025 · CIK: 1099800
| Field | Detail |
|---|---|
| Company | Edwards Lifesciences Corp (EW) |
| Form Type | DEFA14A |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, regulatory, sec-filing
TL;DR
Edwards Lifesciences filed proxy docs, no fee. Standard procedure.
AI Summary
Edwards Lifesciences Corp. filed a Definitive Additional Materials (DEFA14A) on April 14, 2025. This filing is related to their proxy statement and indicates no fee was required for this submission. The company, headquartered in Irvine, CA, operates in the orthopedic, prosthetic & surgical appliances & supplies industry.
Why It Matters
This filing is a routine regulatory submission for Edwards Lifesciences, providing updated proxy materials to shareholders. It does not contain new financial results or strategic announcements.
Risk Assessment
Risk Level: low — This filing is a routine DEFA14A, indicating standard proxy statement materials rather than significant new information or events.
Key Players & Entities
- Edwards Lifesciences Corp. (company) — Registrant
- 0001193125-25-080166 (filing_id) — Accession Number
- 20250414 (date) — Filing Date
- Irvine, CA (location) — Company Headquarters
- 3842 (industry_code) — Standard Industrial Classification
FAQ
What type of filing is this DEFA14A for Edwards Lifesciences Corp.?
This filing is classified as Definitive Additional Materials (DEFA14A).
When was this filing submitted to the SEC?
The filing was submitted on April 14, 2025.
Is there a filing fee associated with this document?
No, the filing indicates that no fee was required.
What is the primary business address of Edwards Lifesciences Corp.?
The primary business address is One Edwards Way, Irvine, CA 92614.
What is the Standard Industrial Classification code for Edwards Lifesciences Corp.?
The SIC code is 3842, which corresponds to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 14, 2025 regarding Edwards Lifesciences Corp (EW).